Gubra A/S
GUBRA
ISIN DK0062266474 / Valor 125706804
Gubra A/S
UMushroom community rating:
About company
Gubra A/S is a specialized company focusing on high-end preclinical contract research and peptide-based drug discovery, particularly within the realms of metabolic and fibrotic diseases. Utilizing advanced models and technologies, Gubra provides rapid and high-quality data through its comprehensive services. The company’s light-sheet microscopy platform enables 3D imaging of organs in mice and rats, while its automated imaging pipeline and AI-driven image analysis ensure precise drug distribution mapping and histological quantification. Gubra offers a range of histology services, including core histology, multiplex immunohistochemistry, RNAScope®, and unbiased stereology analysis. Additionally, the company provides specialized models for cardiovascular diseases, such as hypertension-induced heart failure and atherosclerosis, complemented by state-of-the-art echocardiography and quantitative whole-heart 3D histology. Gubra also excels in peptide drug discovery, leveraging its AI-driven streaMLine platform to develop clinical-ready drug candidates with robust intellectual property protection. The company’s expertise spans linear, cyclic, disulfide-rich peptides, and peptide drug-conjugates, facilitating the transition from target identification to in vivo target validation.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
1135 M
Market cap (USD)
44,914
Daily traded volume (Shares)
634 / 618
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
